Management tracks: Autolus, Bayer, Cambridge Allergy

T cell cancer therapy company Autolus Therapeutics plc (NASDAQ:AUTL) hired Adam Hacker as SVP for regulatory affairs and quality, a newly created position. Previously, he was VP, head of vaccines and scientific innovation projects, global regulatory affairs for the Janssen Pharmaceutical Inc. subsidiary of Johnson & Johnson (NYSE:JNJ).

Bayer AG (Xetra:BAYN) hired Scott Partridge as general counsel of its U.S. division. He succeeds Jan Heinemann. Partridge was VP of global strategy at Monsanto Co., which was acquired by Bayer in June...